Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2023-02-24 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a mandatory regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, including convertible bond acquisitions and collateral agreements, by a major shareholder and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-02-24 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the 'Issuance Results of Paid-in Capital Increase or Equity-Linked Bonds' (specifically convertible bonds). It details the completion of a 40 billion KRW private placement of convertible bonds. Since this relates to the issuance of equity-linked securities and capital changes, it falls under the 'Share Issue/Capital Change' category.
2023-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard preliminary earnings announcement required by the Korea Exchange (KRX) for listed companies. It provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the variance, such as mergers and accounting changes. It explicitly states that these are preliminary figures and subject to audit, which is characteristic of an Earnings Release (ER). FY 2022
2023-02-20 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically marks itself as a 'Correction Report' (정정신고). It details changes to bond maturity dates, interest payment methods, conversion prices, and other financial terms. This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2023-02-17 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding a 'Capital Increase Decision' (유상증자결정) for a subsidiary. It details the issuance of new shares, the purpose of the funds, and the specific terms of the third-party allocation. This falls under the category of share issuance and capital changes.
2023-02-17 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding the 'Acquisition of Shares and Securities of Other Corporations' (타법인주식및출자증권취득결정). It details a correction (정정신고) to a previous filing, specifically updating the acquisition date and shareholding details. Since this is a specific regulatory announcement regarding corporate investment activity that does not fit into the other specialized categories like M&A (which usually implies a takeover or merger) or Share Issue (which is for the company's own capital changes), it is classified as a general Regulatory Filing.
2023-02-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.